Malignant respiratory tract neoplasm Recruiting Phase 1 Trials for Valproic acid (DB00313)

Also known as: Malignant respiratory tract neoplasm NOS / Malignant neoplasm of respiratory tract / Malignant neoplasm of respiratory tract NOS

IndicationStatusPhase
DBCOND0016668 (Malignant respiratory tract neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01552434Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTreatment